Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
BMJ Case Reports|June 21, 2011
Relapsing polychondritis: an uncommon cause of dementiaDeniz Erten-Lyons, Barry Oken, Randall L Woltjer, et al.Plos One|March 8, 2018
Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body DiseasePaul L Wood, Soumya Tippireddy, Joshua Feriante, et al.Metabolites|February 25, 2022
Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson's Disease and Lewy Body DiseaseAaron W Beger, Beatrix Dudzik, Randall L Woltjer, et al.Biochemistry|August 18, 1992
High-yield covalent attachment of epidermal growth factor to its receptor by kinetically controlled, stepwise affinity cross-linkingR L Woltjer, L Weclas-Henderson, I A Papayannopoulos, et al.The Journal of Biological Chemistry|December 7, 2016
The Translational Significance of the Neurovascular UnitHeather L McConnell, Cymon N Kersch, Randall L Woltjer, et al.Archives of Biochemistry and Biophysics|August 1, 1994
Peptide substrate recognition by the epidermal growth factor receptorC A Guyer, R L Woltjer, K J Coker, et al.Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|July 4, 2006
Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's diseaseThomas J Montine, Randall L Woltjer, Catherine Pan, et al.Journal of Lipid Research|February 6, 2008
F2-dihomo-isoprostanes arise from free radical attack on adrenic acidMike VanRollins, Randall L Woltjer, Huiyong Yin, et al.Journal of Alzheimer'S Disease : JAD|February 6, 2004
Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicityRandall L Woltjer, Izumi Maezawa, Joyce J Ou, et al.Genome Medicine|May 28, 2013
Genes and pathways underlying regional and cell type changes in Alzheimer's diseaseJeremy A Miller, Randall L Woltjer, Jeff M Goodenbour, et al.Pageof 13